Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 29, 2010Annals of SurgeryOpen Access

Interval Between Neoadjuvant Chemoradiotherapy and Surgery for Squamous Cell Carcinoma of the Thoracic Esophagus

View Full Paper
Ask AI
Bookmark
Share

Authors

ARAlberto RuolUniversity of PaduaCRChristian RizzettoCa' Foncello HospitalCCCarlo CastoroHumanitas University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ruol et al. (2010) studied this question.

synapsesocial.com/papers/6a8a9c4eec2e105e8ac15827https://doi.org/10.1097/sla.0b013e3181fc7f86
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations1994 · 2,069 citations
  2. 2Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma2001 · 345 citations
  3. 3Influence of the Interval Between Preoperative Radiation Therapy and Surgery on Downstaging and on the Rate of Sphincter-Sparing Surgery for Rectal Cancer: The Lyon R90-01 Randomized Trial1999 · 819 citations
  4. 4Hospital Volume and Late Survival After Cancer Surgery2007 · 634 citations
  5. 5Two Thousand Transhiatal Esophagectomies2007 · 486 citations